Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis2018-01-17T17:04:28-05:00

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial2018-01-17T17:03:58-05:00